C
Registered Attendees

Kevin Anderson

DHS Science & Technology


George Annas

Boston University


Naomi Aronson

Blue Cross and Blue Shield Technology Evaluation Center


LeeAnn Bailey

Deloitte LLP


Robert Becker

U.S. Food and Drug Administration


Judith Benkendorf

American College of Medical Genetics


Jim Black

TRICARE Management Activity


Bruce Blumberg

Kaiser Permanente


Denise Bonds

National Heart, Lung, and Blood Institute


Khaled Bouri

U.S. Food and Drug Administration


Joel V. Brill

Independent


Amy Brower

American College of Medical Genetics


Jonca Bull

Novartis Pharmaceuticals


Ned Calonge

The Colorado Trust



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement



Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 81
C Registered Attendees Kevin Anderson Bruce Blumberg DHS Science & Technology Kaiser Permanente George Annas Denise Bonds Boston University National Heart, Lung, and Blood Institute Naomi Aronson Khaled Bouri Blue Cross and Blue Shield Technology Evaluation Center U.S. Food and Drug Administration LeeAnn Bailey Joel V. Brill Deloitte LLP Independent Robert Becker Amy Brower U.S. Food and Drug Administration American College of Medical Genetics Judith Benkendorf Jonca Bull American College of Medical Genetics Novartis Pharmaceuticals Jim Black Ned Calonge TRICARE Management Activity The Colorado Trust 81

OCR for page 81
82 GENOMIC DIAGNOSTIC TEST DEVELOPMENT Kathryn Camp Amanda Field Office of Dietary Supplements Genetic Alliance National Institutes of Health Andrew Freedman Julie Cantor-Weinberg National Cancer Institute College of American Pathologists Gregory Germino A. Egon Cholakian National Institute of Diabetes and IRDF Project Harvard / Columbia Digestive and Kidney Diseases Melina Cimler Geoffrey Ginsburg Illumina Inc. Duke University Ralph Coates Theresa Gorenc Centers for Disease Control and Avalere Health Prevention Linda Griffith Constanze Coon University of Kansas Medical Deloitte LLP Center Marsha Deckman Manjit Hanspal Peconic Bay Medical Center National Institutes of Health Patricia Deverka Daniel Hayes Center for Medical Technology University of Michigan Policy Comprehensive Cancer Center Melinda DiVito Peter Henderson The National Academies PWHenderson Bernard Edelman Bradford Hirsch Vietnam Veterans of America Duke University Aled Edwards India Hook-Barnard Structural Genomics Consortium The National Academies Robert Epstein Janet Jenkins-Showalter Medco Health Solutions, Inc. Roche William Gregory Feero Sharon Kardia National Human Genome Research University of Michigan School of Institute Public Health

OCR for page 81
83 APPENDIX C Alice Kau Caryn Lerman National Institute of Child Health University of Pennsylvania and Human Development Leslie Levin Alisha Keehn Medical Advisory Secretariat, American College of Medical Ministry of Health & Long- Genetics Term Care James Kelly Hallie Lewis Roche Molecular Systems Cepheid, Inc. Mohamed Khan Adriana Malheiro American Medical Association National Center for Biotechnology Information Muin Khoury Elizabeth Mansfield Centers for Disease Control and Prevention U.S. Food and Drug Administration Roger Klein Robert McCormack BloodCenter of Wisconsin Veridex, LLC. Pei Koay Stephen Michael Chemical Heritage Foundation Policy Directions Inc. Hanns Kuttner James Mills Hudson Institute National Institutes of Health Eric Larson C. Douglas Monroe Group Health Research Institute Kaiser Permanente Meghan Lawson Amy Muhlberg Cepheid, Inc. Life Technologies Teresa Lee Sharon Murphy Advanced Medical Technology Association Institute of Medicine Greg Lennon Kathryn Phillips SNPedia University of California, San Francisco Debra Leonard College of American Pathologists

OCR for page 81
84 GENOMIC DIAGNOSTIC TEST DEVELOPMENT Andre Pilon Fay Shamanski American Association for Cancer College of American Pathologists Research Richard Simon Margaret Piper National Cancer Institute Blue Cross and Blue Shield Scott Steele Technology Evaluation Center University of Rochester Irene Prabhu Das Robin Stombler National Cancer Institute Auburn Health Strategies, LLC Jennifer Puck Fang Sun University of California, San Francisco ECRI Institute Elizabeth Rach Weimin Tang Institute of Medicine ShanghaiBio (US) David Ransohoff Cara Tenenbaum University of North Carolina at Ovarian Cancer National Alliance Chapel Hill Sharon Terry Lynnie Reid Genetic Alliance Boston University School of Barry Thompson Medicine American College of Medical Wendy Rubinstein Genetics NorthShore University Health Martha Turner System American Nurses Association Debi Sarkar Paul Vetter Maternal and Child Health Bureau Health Resources and Services PerkinElmer Administration Michael Watson Thomas Scarnecchia American College of Medical Digital Aurora Genetics Sheri Schully Daniel J. Wattendorf National Cancer Institute Department of the Air Force

OCR for page 81
85 APPENDIX C Meredith Weaver John Yeh American College of Medical Beth Israel Deaconess Medical Genetics Center/Harvard Medical School Catherine Wicklund National Society of Genetic Counselors

OCR for page 81